FDA — authorised 30 September 1963
- Application: NDA014295
- Marketing authorisation holder: MALLINCKRODT
- Local brand name: CONRAY 400
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 IOTHALAMATE SODIUM in United States
FDA authorised IOTHALAMATE SODIUM on 30 September 1963
Marketing authorisations
FDA — authorised 6 May 1976
- Application: NDA013319
- Marketing authorisation holder: MALLINCKRODT
- Local brand name: ANGIO-CONRAY
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 7 September 1976
- Application: NDA017685
- Marketing authorisation holder: MALLINCKRODT
- Local brand name: CONRAY 325
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Status: approved
IOTHALAMATE SODIUM in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is IOTHALAMATE SODIUM approved in United States?
Yes. FDA authorised it on 30 September 1963; FDA authorised it on 6 May 1976; FDA authorised it on 7 September 1976.
Who is the marketing authorisation holder for IOTHALAMATE SODIUM in United States?
MALLINCKRODT holds the US marketing authorisation.